Literature DB >> 9330988

Diagnostic criteria for Alzheimer's disease.

J L Price1.   

Abstract

This paper summarizes changes that distinguish early Alzheimer's disease (AD) from nondemented aging based on 49 well characterized cases (30 nondemented, 10 very mildly demented, and 9 severely demented). Tangles were found in all nondemented cases (aged 54 to 88) concentrated in limbic structures. The probability of high tangle density increases with age, even in the absence of plaques or dementia. Based on plaques, nondemented cases can be divided into three groups: 1) cases younger than 73 years of age with one-third of older cases had no plaques; 2) about one-half of cases over 74 years of age had a few diffuse plaques in restricted patches in the neocortex; 3) about one-quarter of cases over 74 years of age had many neuritic and diffuse plaques throughout the neocortex; these may represent "preclinical" AD. Very mildly demented cases had high concentrations of neuritic and diffuse plaques in the neocortex and tangles in limbic structures. The observations indicate that the minimal diagnostic criterion for AD is plaques throughout the neocortex together with neurofibrillary changes (tangles in limbic structures and neuritic plaques in cortex). Tangles are a necessary but not sufficient criterion.

Entities:  

Mesh:

Year:  1997        PMID: 9330988     DOI: 10.1016/s0197-4580(97)00072-9

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Abnormal event-related potentials in young and middle-aged adults with the ApoE ε4 allele.

Authors:  Krystin Corby; Charlie D Morgan; Claire Murphy
Journal:  Int J Psychophysiol       Date:  2011-11-18       Impact factor: 2.997

2.  17α-estradiol attenuates neuron loss in ovariectomized Dtg AβPP/PS1 mice.

Authors:  Kebreten F Manaye; Joanne S Allard; Sara Kalifa; Amy C Drew; Guang Xu; Donald K Ingram; Rafael de Cabo; Peter R Mouton
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal.

Authors:  Liana G Apostolova; Lisa Mosconi; Paul M Thompson; Amity E Green; Kristy S Hwang; Anthony Ramirez; Rachel Mistur; Wai H Tsui; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2008-09-24       Impact factor: 4.673

4.  Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.

Authors:  Hiroshi Ito; Hitoshi Shinotoh; Hitoshi Shimada; Michie Miyoshi; Kazuhiko Yanai; Nobuyuki Okamura; Harumasa Takano; Hidehiko Takahashi; Ryosuke Arakawa; Fumitoshi Kodaka; Maiko Ono; Yoko Eguchi; Makoto Higuchi; Toshimitsu Fukumura; Tetsuya Suhara
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04       Impact factor: 9.236

5.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

6.  Use of the Quick Dementia Rating System (QDRS) as an Initial Screening Measure in a Longitudinal Cohort at Risk for Alzheimer's Disease.

Authors:  Sara E Berman; Rebecca L Koscik; Lindsay R Clark; Kimberly D Mueller; Lisa Bluder; James E Galvin; Sterling C Johnson
Journal:  J Alzheimers Dis Rep       Date:  2017-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.